Medicrea to Host Investor Meetings During the 35th Annual J.P. Morgan Healthcare Conference

LYON, France & NEW YORK–(BUSINESS WIRE)– The MEDICREA Group (Alternext Paris: FR0004178572 – ALMED), worldwide
leader pioneering the development and manufacture of personalized
analytical services and implant solutions for the treatment of complex
spinal conditions, announced today that the Company will host one-on-one
investor meetings during the 35th Annual J.P. Morgan Healthcare
Conference as part of the LifeSci Advisors Corporate Access Event at the
Sir Francis Drake Hotel in San Francisco, CA. Denys SOURNAC, President
and CEO, Richard ‘Rick’ KIENZLE, Chief Commercial and Business
Development Officer, and Fabrice KILFIGER, Chief Financial Officer, will
be available for meetings beginning Monday, January 9 until Wednesday,
January 11, 2017. Interested parties should contact Brian RITCHIE via
email at britchie@lifesciadvisors.com
to schedule a meeting.

About MEDICREA (www.medicrea.com)

MEDICREA specializes in bringing pre-operative digital planning and pre
and post-operative analytical services to the world of complex spine.
Through the lens of predictive medicine, MEDICREA leads the design,
integrated manufacture, and distribution of 30+ FDA approved implant
technologies, utilized in over 100k spinal surgeries to date. Operating
in a $10 billion marketplace, MEDICREA is an SME with 150 employees
worldwide, which includes 55 at its USA Corp. subsidiary in NYC. The
Company has an ultra-modern manufacturing facility in Lyon, France
housing the development and production of 3D-printed titanium
patient-specific implants.

By leveraging its proprietary software analysis tools with big data and
deep learning technologies supported by an expansive collection of
clinical and scientific data, MEDICREA is well-placed to streamline the
efficiency of spinal care, reducing procedural complications and
limiting time spent in the O.R.

For further information, please visit: medicrea.com.

Connect with MEDICREA:
FACEBOOK
| INSTAGRAM
| TWITTER
| WEBSITE
| YOUTUBE

MEDICREA is listed on ALTERNEXT Paris ISIN: FR 0004178572 – Ticker:
ALMED

View source version on businesswire.com: http://www.businesswire.com/news/home/20170105006519/en/